(Q34629955)

3 August 2017

1 reference

23 September 2020

1 reference

randomized controlled trial

1 reference

title

Dose intensity in cancer chemotherapy (English)

1 reference

antineoplastic combined chemotherapy protocols

3 August 2017

1 reference

23 September 2020

1 reference

23 September 2020

1 reference

23 September 2020

1 reference

1 reference

23 September 2020

1 reference

ORCID Public Data File 2021

author name string

Dodwell DJ

series ordinal

1

1 reference

3 August 2017

Gurney H

series ordinal

2

1 reference

3 August 2017

Thatcher N

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 June 1990

6 references

British Journal of Cancer

3 August 2017

13 March 2019

3 April 2019

17 June 2019

25 June 2019

23 September 2020

6 references

3 August 2017

13 March 2019

3 April 2019

17 June 2019

25 June 2019

23 September 2020

61

1 reference

3 August 2017

issue

6

1 reference

3 August 2017

page(s)

789-794

1 reference

Methotrexate treatment of squamous-cell head and neck cancers: dose-response evaluation

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971684

The importance of dose intensity in chemotherapy of metastatic breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971684

The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971684

Drug dosage and remission duration in childhood lymphocytic leukemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971684

Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971684

A phase I-II study of intensive-dose adriamycin for advanced breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971684

Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971684

Dose-response in the treatment of breast cancer: a critical review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971684

Autologous bone marrow transplantation for patients with poor-prognosis lymphoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971684

Treatment intensity and outcome for children with acute lymphocytic leukemia of standard risk. A Pediatric Oncology Group Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971684

Influence of dose intensity and density on therapeutic and toxic effects in Hodgkin's disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971684

Bone marrow transplantation in the treatment of patients with lymphoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971684

The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971684

A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971684

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971684

A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971684

Intensive chemotherapy of small cell bronchogenic carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971684

Randomized dose-response evaluation of etoposide in small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial

7 July 2018

1 reference

12 December 2020

A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma

1 reference

12 December 2020

Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study

1 reference

12 December 2020

Dose intensity analysis of chemotherapy regimens in ovarian carcinoma

1 reference

12 December 2020

The description of chemotherapy delivery: options and pitfalls

1 reference

12 December 2020

Dose intensity analysis of melphalan and prednisone in multiple myeloma

1 reference

12 December 2020

Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease

1 reference

12 December 2020

Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo

1 reference

12 December 2020

Adjuvant chemotherapy of breast cancer

1 reference

12 December 2020

Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study

1 reference

12 December 2020

A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy

1 reference

12 December 2020

Increased therapeutic index of weekly doxorubicin in the therapy of non-small cell lung cancer: a prospective, randomized study

1 reference

12 December 2020

Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology

1 reference

12 December 2020

Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer

1 reference

12 December 2020

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1990.178

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference